Anti-microbial composition
AssigneeSepteos
InventorNicolas TESSE
Life of this patent
Estimating the term…
Abstract
This invention pertains to an anti-microbial, in particular anti-bacterial and/or anti-fungal composition comprising cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate and linalool. In particular this composition is intended for preventing and/or treating microbial infection in an animal.
Claims8
A method for antimicrobial prevention or treatment, said method comprising:
- administering to a patient in need thereof a composition comprising:
- an active blend comprising, or consisting of:
- trans-cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate, and linalool,
- optionally cineole, beta-caryophyllene, and/or benzyl benzoate,
- optionally a drug,
- optionally a carrier,
- wherein the total amount of coumarin and/or safrole is below 1% by weight compared to the total weight of the composition, and
- wherein the composition comprises at least one pharmaceutical acceptable excipient.
A method for preventing or treating infections resulting from resistant bacteria or fungi or viruses, said method comprising:
- administering to a patient in need thereof a composition comprising:
- an active blend comprising, or consisting of:
- trans-cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate, and linalool,
- optionally cineole, beta-caryophyllene, and/or benzyl benzoate,
- optionally a drug,
- optionally a carrier,
- wherein the total amount of coumarin and/or safrole is below 1% by weight compared to the total weight of the composition,
- wherein the composition comprises at least one pharmaceutical acceptable excipient.
A method for antimicrobial prevention or treatment, said method comprising:
- administering to a patient in need thereof a synthetic composition comprising:
- an active blend including:
- trans-cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate, and linalool,
- at least cineole, and/or benzyl benzoate,
- optionally beta-caryophyllene,
- wherein the number of compounds in the active blend is equal to or lower than seven,
- optionally a drug,
- optionally a carrier,
- wherein the composition is free of coumarin and safrole, and
- wherein the synthetic composition comprises at least one pharmaceutical acceptable excipient.
A method for preventing or treating infections resulting from resistant bacteria or fungi or viruses, said method comprising:
- administering to a patient in need thereof a synthetic composition comprising:
- a synthetic composition comprising:
- an active blend including:
- trans-cinnamaldehyde, trans-2-methoxycinnamaldehyde, cinnamyl acetate, and linalool,
- at least cineole, and/or benzyl benzoate,
- optionally beta-caryophyllene,
- wherein the number of compounds in the active blend is equal to or lower than seven,
- optionally a drug,
- optionally a carrier,
- wherein the composition is free of coumarin and safrole, and
- wherein the composition comprises at least one pharmaceutical acceptable excipient.
Dependencies are inferred from the claim text.